PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91020F00025 — DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEO…

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEO… is a federal award for Department of Health and Human Services (HHS) held by LEIDOS BIOMEDICAL RESEARCH, INC.. Estimated value $97.5M ($85.1M obligated). Current period of performance ends Sep 24, 2028. Place of performance: FREDERICK, MD.

$97.5M
Estimated Value
$85.1M
Obligated
Sep 24, 2028
PoP End / Expires

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

LEIDOS BIOMEDICAL RESEARCH, INC. holds $2.3B across 187 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. Recompete timing centers on the Sep 24, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

Federal
Contract number75N91020F00025
AgencyDepartment of Health and Human Services (HHS)
IncumbentLEIDOS BIOMEDICAL RESEARCH, INC.
UEIHV8BH9BPG8Y9
NAICS541715
PSCAN12
Parent IDIQ / IDV75N91019D00024
Place of performanceFREDERICK, MD
PoP end (current)Sep 24, 2028
Obligated$85.1M

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR

Recompete timing

Public
Expiring in 770 days

Current PoP ends Sep 24, 2028 (770 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 24, 2027.

Watch this contract — one email →

Incumbent footprint

Public record

LEIDOS BIOMEDICAL RESEARCH, INC.$2.3B obligated across 187 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$2.3B · 100% of firm total
Open full company profile

Related awards

Same parent · incumbent
75N91021F00013
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$81.1M
Aug 31, 2026
75N91020F00026
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$56.5M
May 25, 2027
75N91020F00009
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$89.6M
Jul 31, 2028
75N91019F00139
MD NET
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$163.5M
Sep 29, 2028
75N91020F00039
NIAID COVID-19 ACTIV3
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$281.6M
Sep 29, 2029

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open LEIDOS BIOMEDICAL RESEARCH, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75N91020F00025?

75N91020F00025 (DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEO…) is a Department of Health and Human Services (HHS) award with an estimated value of $97.5M, currently held by LEIDOS BIOMEDICAL RESEARCH, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75N91020F00025?

LEIDOS BIOMEDICAL RESEARCH, INC. is the incumbent with $2.3B across 187 related awards in SCOUT’s public footprint. The current period of performance ends Sep 24, 2028.

When does 75N91020F00025 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 24, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91019D00024-75N91020F00025